44
Revised Model of Endocannabinoid Signaling

Revised Model of Endocannabinoid Signaling

  • Upload
    walker

  • View
    44

  • Download
    2

Embed Size (px)

DESCRIPTION

Revised Model of Endocannabinoid Signaling. Cannabinoids Medically and traditionally used for thousands of years Active compound of marijuana ( D 9 -THC) identified in 1964 Brain cannabinoid receptor (CB1) identified in 1990. - PowerPoint PPT Presentation

Citation preview

Page 1: Revised Model of Endocannabinoid Signaling

Revised Model of Endocannabinoid Signaling

Page 2: Revised Model of Endocannabinoid Signaling

Cannabinoids

• Medically and traditionally used for thousands of years

• Active compound of marijuana (D9-THC) identified in 1964

• Brain cannabinoid receptor (CB1) identified in 1990.

• CB1 is one of the most abundant G-protein coupled receptors in the brain

• Another receptor (CB2) is absent in brain, but enriched in immune tissues

• Most (but not all) effects of D9-THC are absent in CB1-/- mice

• “CBX” receptor may exist

Page 3: Revised Model of Endocannabinoid Signaling

Cannabinoids

At central synapses (hippocampus, cerebellum, neocortex), cannabinoids are released in an activity dependent way, and inhibit presynaptic neurotransmitter release

(Depolarization induced Supression of Inhibition/Excitation)

Page 4: Revised Model of Endocannabinoid Signaling

Depolarization induced suppression of inhibition (DSI)

Page 5: Revised Model of Endocannabinoid Signaling

The First Problem

Page 6: Revised Model of Endocannabinoid Signaling

CannabinoidsEndocannabinoids

Synthetic cannabinoids

Page 7: Revised Model of Endocannabinoid Signaling

Direct modulation of ligand-gated ion channels:

Acetylcholine receptor, Serotonin 5HT3 receptor(frog oocyte experiments)

Receptors

IC50

Reference

AchR - -7

118 nM 2-AG 163 nM Anandamide 1.03 µM CP 55,940 3.2 µM WIN 5521,2

Oz et al., 2004

5-HT3-R 3.7 µM Anandamide Oz et al., 2002

h5-HT3-R >1 µM SR141617A 129.6 nM Anandamide 646,7 nM CP 55,940 103.5 nM WIN 5521,2

Barann et al., 2002

AMPAR GluR-1 GluR-3 GluR-1/3 GluR-2/3

161 µM 143 µM Anandamide 148 µM 241 µM

Akinshola et al., 1999

NMDAR NR1-NR2A

Potentiation

20% 1µM Anandamide max 50% with 10 µM

Hampson et al., 1998

Page 8: Revised Model of Endocannabinoid Signaling

Direct modulation of ligand-gated ion channels:

Acetylcholine receptor, Serotonin 5HT3 receptor(frog oocyte experiments)

Page 9: Revised Model of Endocannabinoid Signaling

Research questions

Do cannabinoids modulate GABAergic synaptic transmission by a direct action on

ionotropic GABAA receptors?

If yes, what does this modulation mean for local neuronal circuits

Page 10: Revised Model of Endocannabinoid Signaling

CB1R agonists modulate currents through recombinant GABAAR

Page 11: Revised Model of Endocannabinoid Signaling

CB1R agonists modulate currents through recombinant GABAAR

Page 12: Revised Model of Endocannabinoid Signaling

Cannabinoids show CB1 receptor independent reduction of GABAA mediated response

Page 13: Revised Model of Endocannabinoid Signaling

Experimental Procedure

Paired recordings from a FS interneuron innervating a pyramidal neuron

Page 14: Revised Model of Endocannabinoid Signaling

Cannabinoids show CB1 receptor independent reduction of GABAA mediated response

Page 15: Revised Model of Endocannabinoid Signaling

Cannabinoids show CB1 receptor independent reduction of GABAA mediated response

Page 16: Revised Model of Endocannabinoid Signaling

Postsynaptic depolarization causes a CB1R-independent suppression of inhibitory synaptic transmission.

Page 17: Revised Model of Endocannabinoid Signaling

Endocannabinoid synthesis and degradation

Diacylglycerol Lipase (DAGL)Monoacylglycerol Lipase (MAGL)Cyclooxygenase-2 (COX-2)Fatty acid amide hydrolase (FAAH)

Page 18: Revised Model of Endocannabinoid Signaling

Anandamide synthesis and degradation

Page 19: Revised Model of Endocannabinoid Signaling

Postsynaptic depolarization causes a CB1R-independent suppression of inhibitory synaptic transmission.

RHC80267 & THL: Diacylglycerol Lipase inhibitorsURB602 Monoacylglycerol Lipase inhibitorNimesulide: Cyclooxygenase-2 inhibitor

Page 20: Revised Model of Endocannabinoid Signaling

Modulation of microcircuit coupling by cannabinoids

Page 21: Revised Model of Endocannabinoid Signaling

The effect of CP on hippocampal CCK-positive interneuron to CA1 pyramidal neuron connections in wild-type, CB1R-/- and GABAAR a2

-/- mice.

Page 22: Revised Model of Endocannabinoid Signaling

Potentiation of extrasynaptic GABAARs by endocannabinoids

Page 23: Revised Model of Endocannabinoid Signaling

Dual effect of cannabinoids on GABAARs

Page 24: Revised Model of Endocannabinoid Signaling

Conclusions

These results indicate that:

1. Cannabinoids in addition to the presynaptic (retrograde) mode of action, can suppress inhibition by a direct modulation of postsynaptic GABAA receptors.

2. Suppression of inhibition by a direct modulation of postsynaptic GABAA receptors has a high impact on a neuronal network activity providing a new dimension in cannabinoid signaling.

Page 25: Revised Model of Endocannabinoid Signaling

Golovko Tatiana Heidelberg University Falconer Caroline Dundee University

Min Rogier Lozovaya Natalia Vrije Universiteit AmsterdamBurnashev Nail Institut de Neurobiologie de la Méditerranée

Page 26: Revised Model of Endocannabinoid Signaling

Depolarization induced suppression of inhibition (DSI)

R I Wilson, R A Nicoll Science 2002;296:678-682

Page 27: Revised Model of Endocannabinoid Signaling

Chronic Suppression of Inhibition (CSI)

WT

CB1 KO

Control AM 251

Page 28: Revised Model of Endocannabinoid Signaling

• Chronic suppression of inhibition (CSI) ?

• Pre- or postsynaptic origin?

• Suitable candidate(s) for mediating the effect ?

• Presynaptic calcium regulation?

Page 29: Revised Model of Endocannabinoid Signaling

CCK (CB1R +) interneurons

100 msPre

Post100 pA50 mV

CCK

PYR

CCK

Location Firing pattern

Asynchronous release Recording protocol

20 mV200 ms

Vh=-70 mVPost CA1 pyr

20 pA

CCK

PYR

50 ms

Pre CB1 interneuroneVm=-65 mV

Page 30: Revised Model of Endocannabinoid Signaling

SR/AM

Blocking CB1Rs relieves CSI

Page 31: Revised Model of Endocannabinoid Signaling

IPSCs potentiated in WT but not CB1 KO mice

Page 32: Revised Model of Endocannabinoid Signaling

THL

Blocking 2-AG synthesis has no effect on CSI

2AG

THL

Page 33: Revised Model of Endocannabinoid Signaling

Chelation of presynaptic calcium potentiates IPSCs

CCK CCKCCKPYR PYR PYR

AM251

Page 34: Revised Model of Endocannabinoid Signaling

A presynaptic calcium-dependent process suppresses IPSCs

AM AMEGTA EGTA

Page 35: Revised Model of Endocannabinoid Signaling

Half maximal IPSC potentiation with 0.1 mM BAPTA

Page 36: Revised Model of Endocannabinoid Signaling

Brief extracellular BAPTA application potentiates IPSCs

CCK

BAPTA

10 mM

PYR

Page 37: Revised Model of Endocannabinoid Signaling

CSI time course

AEA/2-AG/CP+

Page 38: Revised Model of Endocannabinoid Signaling

AEA a potential candidate mediating CSI

Page 39: Revised Model of Endocannabinoid Signaling

Presynaptic calcium regulation: frequency dependence

CCKPYR

CB1R

GABAbR

7 s 12 s 30 s 7 s

Page 40: Revised Model of Endocannabinoid Signaling

What : CSIWhere : PresynapticWho : Anandamide

Why:

Page 41: Revised Model of Endocannabinoid Signaling

Perisomatic inhibition

Freund T and Katona, Neuron 2007; 56:33-42

Page 42: Revised Model of Endocannabinoid Signaling

Synaptic inputs

Freund T, TINS 2003; 489-495

Page 43: Revised Model of Endocannabinoid Signaling

.When: In vivo firing patterns

Page 44: Revised Model of Endocannabinoid Signaling

Bolshakov Alex Falconer CarolineCarl Holmgren Dundee University